Literature DB >> 1292885

Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion.

C Carey1, M R Siegfried, X L Ma, A S Weyrich, A M Lefer.   

Abstract

Splanchnic artery occlusion (SAO) of the celiac, superior mesenteric, and inferior mesenteric arteries for 2 hr, followed by a 2-hr reperfusion period in cats produces a severe form of circulatory shock characterized by endothelial dysfunction, increased lysosomal leakage, and severe hypotension resulting from release of proteases, oxygen-derived free radicals, and other humoral mediators into the circulation. Administration of 0.75 mg/kg/hr of C873754, a nitric oxide (NO) donor, 10 min prior to reperfusion, significantly attenuated the accumulation of plasma cathepsin D from 12 +/- 3 U/ml in the SAO + vehicle group to 5 +/- 1 U/ml (P < 0.05) in the C87-3754 treated SAO group. A similar attenuation of plasma myocardial depressant factor (MDF) activity was observed in the C87-3754 treated cats (P < 0.02). Administration of C87-3754 significantly increased short term (i.e., 2-hr) survival rate (P < 0.05, compared to the vehicle group). Moreover, C87-3754 attenuated the SAO shock induced decline in release of endothelium-derived relaxing factor (EDRF) from isolated superior mesenteric artery (SMA) rings stimulated by acetylcholine and A23187. Additionally, C87-3754 significantly decreased PMN adherence to the superior mesenteric venous endothelium in vitro. Thus, treatment with the NO donor, C87-3754 reduced the accumulation of humoral mediators into the plasma while significantly attenuating endothelial dysfunction and improving short term survival.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1292885

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  14 in total

1.  Role of endogenous and exogenous nitric oxide on intestinal mucosa and microflora in the rat.

Authors:  L Cuzzolin; A Adami; F Crivellente; G Benoni
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

2.  Olprinone attenuates the development of ischemia/reperfusion injury of the gut.

Authors:  Concetta Crisafulli; Emanuela Mazzon; Maria Galuppo; Irene Paterniti; Rocco Caminiti; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2010-03-27       Impact factor: 17.440

3.  Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.

Authors:  S Cuzzocrea; E Mazzon; L Dugo; A P Caputi; K Aston; D P Riley; D Salvemini
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Authors:  D Altavilla; F Squadrito; L Ammendolia; G Squadrito; G M Campo; P Canale; M Ioculano; C Musolino; A Alonci; A Sardella; G Urna; A Saitta; A P Caputi
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

5.  Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; G M Campo; M Ioculano; P Canale; F Rossi; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 6.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

7.  Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock.

Authors:  F Roviezzo; S Cuzzocrea; A Di Lorenzo; V Brancaleone; E Mazzon; R Di Paola; M Bucci; G Cirino
Journal:  Br J Pharmacol       Date:  2007-04-23       Impact factor: 8.739

Review 8.  Membrane tubulovesicular extensions (cytonemes): secretory and adhesive cellular organelles.

Authors:  Svetlana I Galkina; Natalia V Fedorova; Vladimir I Stadnichuk; Galina F Sud'ina
Journal:  Cell Adh Migr       Date:  2013-01-03       Impact factor: 3.405

9.  Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat.

Authors:  Stefania Marzocco; Emanuela Mazzon; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-17       Impact factor: 3.000

10.  Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; P Canale; M Ioculano; G M Campo; L Ammendolia; M Ferlito; B Zingarelli; G Squadrito; A Saitta
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.